Tungsten Signs Dana Farber Cancer Institute And Fresenius Medical Care NA

By  |  September 26, 2014
 | 

E-Invoicing platform provider Tungsten Network has announced two new pharmaceutical businesses have selected them for e-invoicing; Dana-Farber Cancer Institute, a world leader in cancer treatment and research, and Fresenius Medical Care NA, a US-based provider of kidney dialysis services and renal care products, and

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    “The pharmaceutical sector has been an early adopter of e-Invoicing with our first customer from the industry joining the network in 2004,” says Edmund Truell, Tungsten Group CEO. “It’s befitting that an industry focused on innovation is equally pioneering in its own business practices.”

    These new customers join t GlaxoSmithKline on Tungesten’s platform. The company reports that seven of the twelve largest pharmaceutical companies in the world, ranked by revenue, transact with their suppliers through Tungsten Network.

     

     


    Recommended

    Nvidia Bets on Open Models to Power AI Agents

    Cross-Border Payments Demand Active FX Management

    MassPay Integrates Visa Direct to Speed Cross-Border Payouts

    Digital Bank N26 Names CEO and Faces New Sanctions

    Gemini prediction market

    Gemini Adds Prediction Markets to Financial Super App in US

    See More In: ,